Table 4.

Changes in Week 24 ACR core components.

ACR Core ComponentCanadaSwedenOverall Study Population
SJC–7.3*–6.7*–7.1*
–7.7**–7.5**–7.7**
TJC–9.1*–8.7*–9.0*
–10.2**–7.5**–9.7**
MD global assessment of disease–33.4*–40.2*–35.1*
–40.5**–45.6**–41.5**
Patient global assessment of disease–30.1*–26.5*–29.2*
–32.5**–22.4**–30.7**
Patient pain–27.0*–21.9*–25.7*
–27.4**–23.0**–26.6**
HAQ-DI–0.5*–0.3*–0.4*
–0.5**–0.3**–0.5**
ESR, mm/h–14.3*–20.6*–16.0*
–16.4**–29.4**–18.7**
CRP, mg/dl–14.7*–20.1*–16.1*
–12.2**–28.3**–15.3**
  • * Primary treatment period.

  • ** Retreatment. SJC: swollen joint count; TJC: tender joint count; HAQ-DI: Health Assessment Questionnaire Disability Index; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein.